Skip to content
Clinical Trial Events

Digital Health & AI Innovation Summit

Oct 7–9

Oct 7–9, 2024 Ended

Boston Marriott Cambridge · In person

Meet world-class experts and thought leaders who shape the future of digital health and AI. Stay on top of the trends in your industry and arm yourself to advance your future career.

Venue
Boston Marriott Cambridge
Program
14 tracks · 99 sessions
135 speakers
Organizer
WorldBI

Agenda

All times EDT
  1. 7:00 AM

    60 min

  2. 8:00 AM

    20 min

    Keynote · AI-Powered Precision Medicine in Pharma & Healthcare

    Large Language Models for the Future of Precision Medicine

    David Sontag, MIT

  3. 8:20 AM

    20 min

    Talk · AI-Powered Precision Medicine in Pharma & Healthcare

    Digital Twins and Precision Medicine

    Anthony Chang, Children’s Hospital of Orange County (CHOC)

  4. 8:40 AM

    20 min

    Talk · AI-Powered Precision Medicine in Pharma & Healthcare

    Convergence of AI and Digital Measures for Seamless Preclinical to Clinical Translation

    Szczepan Baran, VeriSIM Life Charmaine Demanuele, Pfizer R&D

  5. 9:00 AM

    20 min

    Talk · AI-Powered Precision Medicine in Pharma & Healthcare

    Responsible AI for Safe, Ethical, and Effective Health AI Solutions

    Tina Hernandez-Boussard, Stanford School of Medicine

  6. 9:20 AM

    20 min

    Talk · AI-Powered Precision Medicine in Pharma & Healthcare

    Expanding AI Internationally Through Partnerships

    Gil Alterovitz, Harvard Medical School

  7. 9:40 AM

    20 min

    Keynote · AI-Powered Precision Medicine in Pharma & Healthcare

    Creating and Scaling AI in Healthcare: Collaborative Intelligence

    Ami Bhatt, American College of Cardiology

  8. 10:00 AM

    30 min

    Break

    Coffee Break

  9. 10:30 AM

    20 min

  10. 10:50 AM

    20 min

    Fireside chat · Rewiring Our World to Work with Human-AI Teams

    Healthcare AI in the Metaverse

    Tjasa Zajc, Faces of Digital Health Carina Kaiser, Chiesi

  11. 11:10 AM

    20 min

    Talk · Rewiring Our World to Work with Human-AI Teams

    Multimodal Video-based Biomarkers for Monitoring Tardive Dyskinesia and Related Mental Health Disorders

    Loren Larsen, Videra Health Owen Muir, Fermata

  12. 11:30 AM

    20 min

    Talk · Rewiring Our World to Work with Human-AI Teams

    Leveraging AI and Wearable Technology for Healthcare Delivery

    Louis Faust, Mayo Clinic

  13. 11:50 AM

    20 min

    Talk · Rewiring Our World to Work with Human-AI Teams

    Real-World Data and AI for Medical Research and Personalized Medicine

    Joseph Zabinski, OM1, Inc.

  14. 12:10 PM

    20 min

    Talk · Rewiring Our World to Work with Human-AI Teams

    The Magic of Web-AI: Turning AI-enabled Web Apps into Clinical Solutions

    Jason Mayes, Google Amir Lahav, SkyMedAI

  15. 12:30 PM

    60 min

    Break

    Lunch Break

  16. 1:30 PM

    20 min

    Keynote · Things We Wish We Knew Before Talking to Investors, Payers, and Regulators

    Ensuring Patient-Centered AI Development and Alignment for the Decade Ahead

    Brian Anderson, Coalition for Health AI (CHAI)

  17. 1:50 PM

    20 min

    Talk · Things We Wish We Knew Before Talking to Investors, Payers, and Regulators

    Foundational Models in Imaging and Impact to Drug Development

    Mariann Micsinai-Balan, Bristol Myers Squibb

  18. 2:10 PM

    20 min

    Talk · Things We Wish We Knew Before Talking to Investors, Payers, and Regulators

    Three Tips on Testing AI: Observations from A Veteran Scientist

    Stan Kachnowski, Columbia University

  19. 2:30 PM

    40 min

    Panel · Things We Wish We Knew Before Talking to Investors, Payers, and Regulators

    How to Talk to Payers & Regulators About Novel Algorithms, Digital Measures, and SaMD Products

    Jonathan Helfgott, Johns Hopkins University Gul Erdemli, Novartis Liz Kwo, Everly Health Marty Culjat, EVERSANA Kyle Y. Faget, Foley & Lardner LLP John Axerio-Cilies, Tempus AI

  20. 3:10 PM

    20 min

    Talk · Things We Wish We Knew Before Talking to Investors, Payers, and Regulators

    The Importance of Clinical Evidence and What Entrepreneurs Need to Know

    Joseph Kvedar, Harvard Medical School

  21. 3:30 PM

    30 min

    Break

    Coffee Break

  22. 4:00 PM

    40 min

    Panel · Clinical Evidence is Not Enough: How Digital Entrepreneurs Secure the Funding They Need?

    Digital Health Fundraising & Investment Advice from VC Experts

    Ritesh Patel, FINN Partners Michael Greeley, Flare Capital Partners Dana Sun, Laerdal Million Lives Fund Laura Hilty, HealthX Ventures Julia Croxen, Rock Health Karl Hess, Outcome Capital

  23. 4:40 PM

    15 min

    Talk · Clinical Evidence is Not Enough: How Digital Entrepreneurs Secure the Funding They Need?

    Why Great Ideas Fail and How Good Partnership Can be a Gamechanger?

    Laura Hilty, HealthX Ventures

  24. 4:55 PM

    5 min

    Other · Clinical Evidence is Not Enough: How Digital Entrepreneurs Secure the Funding They Need?

    The Magical Pill

  25. 5:00 PM

    40 min

    Panel · What Matters to Patients?

    The Voice of Patients About Digital Health & AI

    Grace Vinton, Amendola Communications Lilly Stairs Dave deBronkart Kate Nycz Thomas Bartlett Grace Cordovano, Enlightening Results

  26. 6:45 PM

    90 min

  1. 7:00 AM

    60 min

  2. 8:00 AM

    20 min

    Talk · Track 1: A Panoramic View of Digital Innovations in Maternal, Child and Mental Health

    Navigating the Sirens of Payors, Practitioners, and Regulators to Get the AI Medicine Market to Work

    Dennis Wall, Stanford University

  3. 8:00 AM

    20 min

    Talk · Track 2: Digital Strategies for Commercial Solutions in Pharma & Healthcare

    Go-to-Market Strategies Commercializing Pathways in Digital Health

    Adam Kaufman, Medtech Advisor

  4. 8:20 AM

    15 min

    Talk · Track 1: A Panoramic View of Digital Innovations in Maternal, Child and Mental Health

    Home-based Testing for Newborns: The Importance of Gut Health and its Impact on Developmental Chronic Immunological Conditions

    Cheryl Sew Hoy, Tiny Health

  5. 8:20 AM

    20 min

    Talk · Track 2: Digital Strategies for Commercial Solutions in Pharma & Healthcare

    Developing and Bringing to Market a DTx for Major Depressive Disorder (MDD)

    Iman Ahmed, Otsuka Precision Health, Inc. Daniel Carpenter, Otsuka Precision Health Inc

  6. 8:35 AM

    15 min

    Talk · Track 1: A Panoramic View of Digital Innovations in Maternal, Child and Mental Health

    Can AI Help Predict and Treat Postpartum Depression?

    Kristen Ellefson, nurtur Martin Frasch, nurtur

  7. 8:40 AM

    15 min

    Talk · Track 2: Digital Strategies for Commercial Solutions in Pharma & Healthcare

    Intelligent Clinical Systems: Moving Beyond the AI Hype

    Ryan Vega, Vantiq

  8. 8:50 AM

    20 min

    Talk · Track 1: A Panoramic View of Digital Innovations in Maternal, Child and Mental Health

    Not Just Small Adults: Advancing Innovation in Pediatrics with Al, Digital Health, and Informatics

    Chethan Sarabu, Cornell Tech

  9. 8:55 AM

    15 min

    Talk · Track 2: Digital Strategies for Commercial Solutions in Pharma & Healthcare

    AI Alchemy: Friend or Foe in Healthcare Transformation

    Chris Bergstrom, AmalgamRx Sara Silacci, AmalgamRx

  10. 9:10 AM

    15 min

    Talk · Track 1: A Panoramic View of Digital Innovations in Maternal, Child and Mental Health

    Pediatric Mental Health Innovation: A Research-Backed AI Approach

    Mady Mantha, Happypillar

  11. 9:10 AM

    15 min

    Talk · Track 2: Digital Strategies for Commercial Solutions in Pharma & Healthcare

    AI Co-Lab: How to innovate and bend the adoption curve with Health Systems

    Kamal Jethwani, Decimal.health LLC

  12. 9:25 AM

    15 min

    Talk · Track 1: A Panoramic View of Digital Innovations in Maternal, Child and Mental Health

    Facing Fears Virtually: A Randomized Controlled Study Comparing VR Intervention vs. Sham for Social Anxiety Disorder

    Gazal Vakili, FrontAct, Sumitomo Pharma

  13. 9:25 AM

    35 min

    Panel · Track 2: Digital Strategies for Commercial Solutions in Pharma & Healthcare

    Digital-Drug Combinations and Personalized Companion Solutions

    Marty Culjat, EVERSANA Amir Zur, Takeda Omar Manejwala, Dario Health Satoshi Iwasaki, The Japan Digital Health Alliance Kirk Keaffaber, Eli Lilly

  14. 9:40 AM

    20 min

    Talk · Track 1: A Panoramic View of Digital Innovations in Maternal, Child and Mental Health

    Reimagining Youth Mental Health With Science-based Digital Innovation

    Renae Beaumont, Weill Cornell Medicine

  15. 10:00 AM

    30 min

    Break

    Coffee Break

  16. 10:30 AM

    15 min

    Talk · Track 1: Data Surveillance and Personalized Care in Modern Trials and RWE Studies

    Remote Patient Management and Personalization of Care

    Agata Blasiak, Roche Information Solutions

  17. 10:30 AM

    20 min

    Talk · Track 2: Remote Patient Monitoring and Digital Disease Management

    Remote Monitoring of Speech and Voice as Clinical Markers of Health Remote

    Adam Vogel, The University of Melbourne Tairmae Kangarloo, Takeda

  18. 10:45 AM

    15 min

    Talk · Track 1: Data Surveillance and Personalized Care in Modern Trials and RWE Studies

    Leveraging AI, Just in Time Networks, Patient Centricity and Precision Oncology for Clinical Trial Enrollment

    Arturo Loaiza-Bonilla, Massive Bio

  19. 10:50 AM

    15 min

    Talk · Track 2: Remote Patient Monitoring and Digital Disease Management

    Lessons Learned While Developing Digital Endpoints for ALS

    Ram Miller, Novartis Institutes for BioMedical Research (NIBR)

  20. 11:00 AM

    15 min

    Talk · Track 1: Data Surveillance and Personalized Care in Modern Trials and RWE Studies

    Lessons learned from implementing a Precision Oncology Platform

    Kenny Wong, xCures

  21. 11:05 AM

    15 min

    Talk · Track 2: Remote Patient Monitoring and Digital Disease Management

    How Smart Hybrid Solutions are Revolutionizing Respiratory Clinical Trials

    Erin Lennox, ZEPHYRx

  22. 11:15 AM

    15 min

    Talk · Track 1: Data Surveillance and Personalized Care in Modern Trials and RWE Studies

    Remote Patient Monitoring and Digital Measures in Clinical Trials

    Joe Dustin, BioFourmis

  23. 11:20 AM

    15 min

    Talk · Track 2: Remote Patient Monitoring and Digital Disease Management

    Unveiling the Ignored Vital Sign: Harnessing Smartphone Biomarkers and Beyond for Predictive Health Insights

    Patrick Tarnowski, OneStep

  24. 11:30 AM

    15 min

    Talk · Track 1: Data Surveillance and Personalized Care in Modern Trials and RWE Studies

    Leveraging Modern Technology to Optimize Clinical Trial Efficiencies

    Storm Stillman, Curebase

  25. 11:35 AM

    15 min

    Talk · Track 2: Remote Patient Monitoring and Digital Disease Management

    Leveraging AI + Voice Biomarkers for Real World Solutions

    Grace Chang, Kintsugi

  26. 11:45 AM

    15 min

    Talk · Track 1: Data Surveillance and Personalized Care in Modern Trials and RWE Studies

    Streamlining Clinical Data Collection and Analysis in Real-World Settings

    Milos Todorovic, Analog Devices

  27. 11:50 AM

    15 min

    Talk · Track 2: Remote Patient Monitoring and Digital Disease Management

    TrialReady: A Digital Platform to Integrate Connected Device Data, ePRO, and Adherence Support in Clinical Trials

    Steve Polyak, Clinical ink

  28. 12:00 PM

    35 min

    Panel · Track 1: Data Surveillance and Personalized Care in Modern Trials and RWE Studies

    Emerging Trends in Data Connectivity & Technology-enabled Solutions for Clinical Trials

    Ebony Dashiell-Aje, BioMarin Pharmaceutical Elisa Cascade, Advarra Dawie Wessels, Signant Health Lesley Solomon, Veda Trials Alexis Moores, Infor

  29. 12:05 PM

    15 min

    Talk · Track 2: Remote Patient Monitoring and Digital Disease Management

    The Role of AI in Remote Patient Management

    Nishit Doshi, Roche Information Solutions

  30. 12:20 PM

    15 min

    Talk · Track 2: Remote Patient Monitoring and Digital Disease Management

    Digital Advancements in Autoimmune Disease Management

    Jin Lee, IMIDeology

  31. 12:35 PM

    55 min

    Break

    Lunch Break

  32. 1:30 PM

    20 min

    Talk · Track 1: Integrating AI/ML-powered Solutions in Clinical Trials & Healthcare Delivery

    Bridge2AI Voice: Cross Industry Consortium for Advancing Voice as a Biomarker of Health

    Yael Bensoussan, USF Health

  33. 1:30 PM

    15 min

  34. 1:45 PM

    20 min

    Talk · Track 2: Transforming Healthcare AI Through Education & Partnerships

    AI Partnerships Take Center Stage: AI-Powered Healthcare Redefining Patient and Provider Experiences

    Daniel Gewecke Daugaard, Dawn Health Anders Tveteraas, Novartis

  35. 1:50 PM

    15 min

    Talk · Track 1: Integrating AI/ML-powered Solutions in Clinical Trials & Healthcare Delivery

    Accelerate Clinical Trials using AI

    Bill Lynch, HumanTrue

  36. 2:05 PM

    30 min

    Panel · Track 1: Integrating AI/ML-powered Solutions in Clinical Trials & Healthcare Delivery

    Unleashing the Power of Conversational AI & Medical Communication Channels

    Mendel Erlenwein, Previva Health Group Gigi Shafai, TransPerfect Agata Blasiak, Roche Information Solutions Arturo Loaiza-Bonilla, Massive Bio Umbereen Nehal, HER Heard

  37. 2:05 PM

    35 min

    Panel · Track 2: Transforming Healthcare AI Through Education & Partnerships

    Upskilling to Work with AI Rather Than Fearing It: What Clinicians Wish Technology Designers Understood

    Amanda Azadian, American Medical Association Chethan Sarabu, Cornell Tech Parisa (Risa) Vatanka, Digital.Health Kalie Dove-Maguire, Evidently Xuemei Cai, Pfizer Raihan Faroqui, Guaranteed

  38. 2:35 PM

    20 min

    Talk · Track 1: Integrating AI/ML-powered Solutions in Clinical Trials & Healthcare Delivery

    Vital Sign Revolution: Combining Remote Photoplethysmography, AI and Wearable Technology

    John Gannon, Blue Spark Technologies

  39. 2:40 PM

    20 min

    Talk · Track 2: Transforming Healthcare AI Through Education & Partnerships

    Key Learnings for Partnering with Pharma and Healthcare Organizations

    Ofer Waks, Pfizer

  40. 2:55 PM

    20 min

    Talk · Track 1: Integrating AI/ML-powered Solutions in Clinical Trials & Healthcare Delivery

    Using AI to Improve Surgical Care in Low-Income Countries

    Mayur Narayan, Rutgers Robert Wood Johnson Medical School Divya Kewalramani, Rutgers Robert Wood Johnson Medical School

  41. 3:00 PM

    20 min

    Fireside chat · Track 2: Transforming Healthcare AI Through Education & Partnerships

    Driving Innovation: Perspectives from a Corporate Venture Capitalist and a Digital Health Startup CEO

    Jin Lee, IMIDeology Cris De Luca, Sanofi Ventures Omri Shor, Medisafe® Connected Health Platform

  42. 3:15 PM

    15 min

    Talk · Track 1: Integrating AI/ML-powered Solutions in Clinical Trials & Healthcare Delivery

    Key Regulatory Insights for Applying Clinical AI/ML SaMDs

    James Hillis, Mass General Brigham

  43. 3:20 PM

    40 min

    Panel · Track 2: Transforming Healthcare AI Through Education & Partnerships

    Transforming the Future of Pharma & Healthcare through Cross Industry Partnerships

    Ritesh Patel, FINN Partners Steffanie Bristol, Bristol Advising LLC, Bacchus Venture Capital Georgia Mitsi, Emerald BioVentures Ricky Choi, Samsung Electronics Aman Gupta, SPAG FINN Partners Abhay Kakde, AstraZeneca

  44. 3:30 PM

    30 min

    Panel · Track 1: Integrating AI/ML-powered Solutions in Clinical Trials & Healthcare Delivery

    Industry Standards & Regulatory Oversight of AI in Healthcare and Drug Development

    Hong Truong, Define Ventures Kerri Conn Haresign, Consumer Technology Association Yael Bensoussan, USF Health Dennis Wall, Stanford University Nina Kottler, Radiology Partners

  45. 7:00 PM

    60 min

  46. 8:00 PM

    60 min

    Other

    The SkyMedAI Late Night Show

    Amir Lahav, SkyMedAI Megan Greenfield, McKinsey Gary Monk, Digital Consulting Ami Bhatt, American College of Cardiology Anna Barnacka, MindMics Carina Kaiser, Chiesi Abhishek Singh, MIT

  47. 9:00 PM

    30 min

  48. 9:30 PM

    30 min

  49. 10:00 PM

    30 min

  1. 7:00 AM

    60 min

  2. 8:00 AM

    20 min

    Talk · Using Wearable Technology in Defining Clinical Trial Endpoints

    A Sensor-based Digital Informatics Approach to Improve Care Outcomes and Clinical Trials

    Mark Gudesblatt, NYU Langone

  3. 8:20 AM

    20 min

    Talk · Using Wearable Technology in Defining Clinical Trial Endpoints

    Innovative Approaches to Sensor Measurements in Patients with ALS

    Marta Karas, Takeda Pharmaceuticals

  4. 8:40 AM

    15 min

    Talk · Using Wearable Technology in Defining Clinical Trial Endpoints

    Using Wearable Tech in Cardiovascular Trials

    Steven Lubitz, Novartis

  5. 8:55 AM

    15 min

    Talk · Using Wearable Technology in Defining Clinical Trial Endpoints

    Validation of Real World Walking Metrics as Digital Endpoints for Clinical Trials

    Teri Rosenbaum-Chou, Modus Health

  6. 9:10 AM

    15 min

    Talk · Using Wearable Technology in Defining Clinical Trial Endpoints

    Integrating Sensor-based Clinical Measures in Gene Therapy Trials in Duchanne Muscular Dystrophy

    Michael Binks, PathfindRx

  7. 9:25 AM

    15 min

    Talk · Using Wearable Technology in Defining Clinical Trial Endpoints

    Wearable Blue Light Dosimetry for Patients with Erythropoietic Protoporphyria

    Amy Dickey, Porphyria Center

  8. 9:40 AM

    20 min

    Talk · Using Wearable Technology in Defining Clinical Trial Endpoints

    Digitally-enabled Endpoint Collection in Heart Failure Trials

    Lauren Bataille, Evinova (An AZ Company)

  9. 10:00 AM

    30 min

    Break

    Coffee Break

  10. 10:30 AM

    20 min

    Talk · Next-Gen Pharma & Healthcare: Reinventing Digital Strategy for Big Returns

    Democratization of Health Data & the Future of Healthcare

    Shyamal Patel, Oura

  11. 10:50 AM

    15 min

    Talk · Next-Gen Pharma & Healthcare: Reinventing Digital Strategy for Big Returns

    Associations Between Wearable Device Metrics and Performance Status in Cancer Patients

    Xuemei Cai, Pfizer

  12. 11:05 AM

    20 min

    Talk · Next-Gen Pharma & Healthcare: Reinventing Digital Strategy for Big Returns

    Modernize Digital Outcome Measures in Autoimmune Diseases

    Michelle Crouthamel, Abbvie

  13. 11:25 AM

    15 min

    Talk · Next-Gen Pharma & Healthcare: Reinventing Digital Strategy for Big Returns

    Accelerating Drug Development in Rare Disease Through Digital Technologies: Pursuing Cures for Rett Syndrome

    Jana von Hehn, Rett Syndrome Research Trust

  14. 11:40 AM

    35 min

    Panel · Next-Gen Pharma & Healthcare: Reinventing Digital Strategy for Big Returns

    Digital Measures in Clinical Trials: Current Challenges and Opportunities for ROI

    Amir Lahav, SkyMedAI Marissa Dockendorf, Merck Stephen Ruhmel, Sanofi Alison Buick, Cumulus Neuroscience Ram Miller, Novartis Institutes for BioMedical Research (NIBR) Ariel Dowling, Takeda Pharmaceuticals USA Inc.

  15. 12:15 PM

    20 min

    Keynote · Next-Gen Pharma & Healthcare: Reinventing Digital Strategy for Big Returns

    Two Steps Forward, Two Steps Backward: Can We See Progress with Digital Adoption in Clinical Development?

    Craig Lipset, Clinical Innovation Partners

  16. 12:35 PM

    60 min

    Break

    Lunch Break

  17. 1:35 PM

    20 min

    Keynote · Validation of Digitally-Derived Endpoints in Neurological Diseases

    How Would We Design Digital Biomarkers for Neurological Diseases if Only the Sky Was a Limit?

    Bibi Bielekova, National Institute of Health (NIH)

  18. 1:55 PM

    20 min

    Talk · Validation of Digitally-Derived Endpoints in Neurological Diseases

    Digital Health Technologies in FTLD Syndromes

    Anne-Marie Wills, Massachusetts General Hospital

  19. 2:15 PM

    20 min

    Talk · Validation of Digitally-Derived Endpoints in Neurological Diseases

    Objective Digital Monitoring of Disease Progression and Evaluation of Motor Function in ALS Studies

    Sharon Tamir, Mitsubishi Tanabe Pharma America, Inc.

  20. 2:35 PM

    20 min

    Talk · Validation of Digitally-Derived Endpoints in Neurological Diseases

    The Road to Deployment of Digital Measurements in Parkinson's: Are We There Yet?

    Mark Frasier, The Michael J. Fox Foundation for Parkinson's Research

  21. 2:55 PM

    20 min

    Fireside chat · Validation of Digitally-Derived Endpoints in Neurological Diseases

    Advancing Alzheimer's Research with Multimodal Digital Measurements

    Bryan Hansen, Johnson & Johnson Marc Jones, Altoida

  22. 3:15 PM

    35 min

    Panel · Validation of Digitally-Derived Endpoints in Neurological Diseases

    Digital Solutions in Pharma: Outsource vs. Develop in-House?

    Alex Koshykov, BeKey Peter Covitz, Alexion Greg Silvesti, Sage Therapeutics Lauren Sunshine, BMS Colin Bower, VivoSense

  23. 3:50 PM

    10 min

    Other · Validation of Digitally-Derived Endpoints in Neurological Diseases

    Closing Remarks

    Amir Lahav, SkyMedAI

  24. 4:00 PM

    30 min

    Networking

    Happy Hour!

Speakers